ABOUT COGNIZANT

Cognizant’s Life Sciences business unit partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our services and products, including the Cognizant® Shared Investigator Platform (SIP), are digitizing interactions between sponsors and investigators across every phase, helping the industry subtract time from clinical development and add it to patient lives. Headquartered in the U.S., Cognizant is ranked 194 on the Fortune 500 and is consistently listed among the most admired companies in the world. To learn more, visit cognizant.com/life-sciences.

VIDEOS

Learn how to overcome obstacles to collaboration that, when left unaddressed, lead to site selection and patient enrollment issues for sponsors and operational challenges for sites.

Industry experts from Eli Lilly and Cognizant share their perspectives on the process and building blocks of end-to-end clinical development, the essential elements of a unified clinical platform, and the benefits and challenges involved in realizing the vision of a unified clinical platform.

View this webinar to find out how the Cognizant® Shared Investigator Platform (SIP) automates the flow of documents connecting sponsor eTMF systems while enhancing site-sponsor collaboration, compounding efficiencies, and accelerating trials.

As clinical trials grow more complex, stakeholders urgently need to improve clinical trial efficiencies. Explore a solution for virtual monitoring, study oversight, and document exchange and collaboration, that enables sites, sponsors, and CROs to adapt to the new normal of conducting clinical trials virtually.

The Cognizant Shared Investigator Platform (SIP) supports a new, site-first approach for streamlining clinical trial processes. The industry’s first single-instance, multi-tenant SaaS solution, Cognizant SIP provides investigators and sponsors with a single technology platform from which they can collaborate and share documents, and harmonize workflows across the clinical trial lifecycle.

Discover how 7 of the top 15 global biopharmaceutical companies came together on a single clinical technology platform and operated through common workflows and common trial documents.

Cognizant Shared Investigator Platform (SIP) is a multi-sponsor collaborative solution for clinical trial site selection, start-up communications, and management. The open design of Cognizant SIP simplifies and accelerates clinical trials by eliminating redundant work for sponsors and clinical sites. This can lead to improved operating efficiencies, reduced costs of building and maintaining in-house technology, quicker study start up and more time spent with patients.

Seven of the top fifteen global biopharmaceutical companies are on a single clinical technology platform, leveraging one environment, operating via common workflows, documents and training.

CONTACT INFORMATION

Cognizant Technology Solutions

Glenpointe Centre West 500 Frank W Burr Blvd

Teaneck, NJ 07666

UNITED STATES

Phone: (267) 271-7288

Contact: Larissa Comis

FEATURED ARTICLES